XML 70 R53.htm IDEA: XBRL DOCUMENT
v3.23.1

Revenue - Seagen Agreement (Details) - Seagen - License Agreement [Member] $ in Millions | 1 Months Ended
--- | ---
Oct. 31, 2022 USD ($) | Sep. 30, 2022 USD ($) item
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |
Non-refundable upfront payment received | $ 50.0 |
Maximum amount of nonrefundable upfront payment receivable |  | $ 650.0
Additional tumor targets | item |  | 2
Buy-up fee |  | $ 35.0
Decrease in certain future milestones |  | 30.00%
Years of sale for royalties payable |  | 10 years
Maximum amount of reimbursement entitled to receive |  | $ 6.5

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of buy-up fee. + References No definition available. + Details
Name: | lvtx_BuyUpFeeAmount
Namespace Prefix: | lvtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of maximum non-refundable upfront payment receivable. + References No definition available. + Details
Name: | lvtx_MaximumNonRefundableUpfrontPaymentReceivable
Namespace Prefix: | lvtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Maximum additional tumor targets number. + References No definition available. + Details
Name: | lvtx_MaximumNumberOfAdditionalTumorTargets
Namespace Prefix: | lvtx_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of maximum reimbursement entitles to received. + References No definition available. + Details
Name: | lvtx_MaximumReimbursementEntitledToReceive
Namespace Prefix: | lvtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Percentage of increase (decrease) in certain future milestones in the event we exercise the buy-up option and pay the buy-up fee. + References No definition available. + Details
Name: | lvtx_PercentageOfIncreaseDecreaseInCertainFutureMilestones
Namespace Prefix: | lvtx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Non-refundable upfront payment received under research and license agreement. + References No definition available. + Details
Name: | lvtx_ResearchAndLicenseAgreementNonRefundableUpfrontPaymentReceived
Namespace Prefix: | lvtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Years of sale for royalties payable under research and license agreement. + References No definition available. + Details
Name: | lvtx_ResearchAndLicenseAgreementRoyaltiesPayableYearsOfSale
Namespace Prefix: | lvtx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_CounterpartiesAxis=lvtx_SeagenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | lvtx_IfrsCollaborativeArrangementAndArrangementOtherThanCollaborativeAxis=lvtx_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |